Os Therapies Incorporated (OSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,397 | -28,754 | -15,293 | -8,414 | -3,877 |
| Depreciation Amortization | 194 | 1,401 | 238 | 113 | 1 |
| Accounts payable and accrued liabilities | 3,882 | 8,274 | 1,712 | 1,041 | -202 |
| Other Working Capital | 3,915 | 9,109 | 2,146 | 1,151 | -299 |
| Other Operating Activity | -2,158 | -4,269 | 689 | 306 | 936 |
| Operating Cash Flow | $-4,564 | $-14,239 | $-10,508 | $-5,802 | $-3,442 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | -466 | -466 | -466 | -150 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -24 |
| Investing Cash Flow | $N/A | $-466 | $-466 | $-466 | $-174 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,835 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 7,858 | 6,264 | 2,484 | N/A |
| Other Financing Activity | 3,376 | 1,583 | 1,054 | 1,054 | 1,053 |
| Financing Cash Flow | $5,211 | $9,441 | $7,318 | $3,537 | $1,053 |
| Beginning Cash Position | 270 | 5,534 | 5,534 | 5,534 | 5,534 |
| End Cash Position | 918 | 270 | 1,877 | 2,802 | 2,971 |
| Net Cash Flow | $648 | $-5,264 | $-3,657 | $-2,732 | $-2,563 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,564 | -14,239 | -10,508 | -5,802 | -3,442 |
| Free Cash Flow | -4,564 | -14,239 | -10,508 | -5,802 | -3,442 |